Steven Cohen's DXCM Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 2.24 M shares of DexCom, Inc. (DXCM) worth $150.46 M, representing 0.25% of the portfolio. First purchased in 2015-Q4, this long-term strategic position has been held for 40 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in DXCM, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2018, adding 3.52 M shares. Largest reduction occurred in Q3 2018, reducing 3.08 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's DexCom (DXCM) Holding Value Over Time
Track share changes against reported price movement
Quarterly DexCom (DXCM) Trades by Steven Cohen
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2015 | +898,800 | New Buy | 898,800 | $20.48 |
| Q1 2016 | +132,800 | Add 14.78% | 1.03 M | $16.98 |
| Q2 2016 | +12,400 | Add 1.20% | 1.04 M | $19.83 |
| Q3 2016 | -309,600 | Reduce 29.66% | 734,400 | $21.91 |
| Q4 2016 | +36,000 | Add 4.90% | 770,400 | $14.92 |
| Q1 2017 | -591,772 | Reduce 76.81% | 178,628 | $21.18 |
| Q2 2017 | +1.32 M | Add 738.76% | 1.5 M | $18.29 |
| Q3 2017 | -978,264 | Reduce 65.29% | 520,000 | $12.23 |
| Q4 2017 | -120,000 | Reduce 23.08% | 400,000 | $14.35 |
| Q1 2018 | +3.52 M | Add 879.18% | 3.92 M | $18.54 |
| Q2 2018 | +984,676 | Add 25.14% | 4.9 M | $23.74 |
| Q3 2018 | -3.08 M | Reduce 62.94% | 1.82 M | $35.76 |
| Q4 2018 | -1.56 M | Reduce 85.82% | 257,656 | $29.95 |
| Q1 2019 | +418,672 | Add 162.49% | 676,328 | $29.78 |
| Q2 2019 | +514,260 | Add 76.04% | 1.19 M | $37.46 |
| Q3 2019 | -280,548 | Reduce 23.56% | 910,040 | $37.31 |
| Q4 2019 | -430,184 | Reduce 47.27% | 479,856 | $54.69 |
| Q1 2020 | -432,668 | Reduce 90.17% | 47,188 | $67.33 |
| Q2 2020 | +12,812 | Add 27.15% | 60,000 | $101.35 |
| Q3 2020 | +541,260 | Add 902.10% | 601,260 | $103.06 |
| Q4 2020 | +205,140 | Add 34.12% | 806,400 | $92.43 |
| Q1 2021 | -678,400 | Reduce 84.13% | 128,000 | $89.84 |
| Q2 2021 | -128,000 | Sold Out | 128,000 | $0.00 |
| Q2 2022 | +908,809 | New Buy | 908,809 | $74.53 |
| Q3 2022 | -78,446 | Reduce 8.63% | 830,363 | $80.54 |
| Q4 2022 | -627,528 | Reduce 75.57% | 202,835 | $113.24 |
| Q1 2023 | +1.36 M | Add 670.08% | 1.56 M | $116.18 |
| Q2 2023 | -1.54 M | Reduce 98.66% | 20,918 | $128.51 |
| Q3 2023 | +792,140 | Add 3786.88% | 813,058 | $93.30 |
| Q4 2023 | -813,058 | Sold Out | 813,058 | $0.00 |
| Q4 2024 | +1.6 M | New Buy | 1.6 M | $77.77 |
| Q1 2025 | -1.21 M | Reduce 75.80% | 386,904 | $68.29 |
| Q2 2025 | -386,904 | Sold Out | 386,904 | $0.00 |
| Q3 2025 | +2.24 M | New Buy | 2.24 M | $67.29 |
Steven Cohen's DexCom Investment FAQs
Steven Cohen first purchased DexCom, Inc. (DXCM) in Q4 2015, acquiring 898,800 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held DexCom, Inc. (DXCM) for 40 quarters since Q4 2015. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen's largest addition to DexCom, Inc. (DXCM) was in Q1 2018, adding 3,916,700 shares worth $72.62 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 2,235,987 shares of DexCom, Inc. (DXCM), valued at approximately $150.46 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, DexCom, Inc. (DXCM) represents approximately 0.25% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen's peak holding in DexCom, Inc. (DXCM) was 4,901,376 shares, as reported at the end of Q2 2018. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.